MDMA-Assisted Therapy for Treatment-Resistant PTSD

The client, a 56-year-old woman with PTSD of 20 years' duration (childhood sexual abuse, multiple failed treatments including SSRIs, EMDR, and inpatient programs), completed the standard MDMA-assisted therapy protocol (3 preparatory sessions, 3 MDMA sessions, 9 integration sessions) over 5 months. This case study documents the process and 24-month outcomes.

The client's CAPS-5 score at baseline was 58 (severe). After the first MDMA session, she reported: 'For the first time, I could feel the memories without being destroyed by them.' After the third session, her CAPS-5 score was 22 (subclinical). At 24-month follow-up, her score was 16, and she no longer met criteria for PTSD. She reported sustained improvement in relationships, employment, and quality of life.

The case highlights the role of the therapeutic relationship. The client identified the non-judgmental presence of the co-therapists as the most important factor: 'They weren't afraid of what I was feeling. That let me not be afraid of it either.' The MDMA did not erase the memories; it changed the client's relationship to them — from overwhelming to bearable, from defining to contextual. The case supports the model that MDMA's primary therapeutic action is the temporary reduction of fear-based avoidance, allowing the therapeutic work to proceed.